블로그
- Tirzepatide sodium salt [B1370-449939][CAS no. 2933217-72-0]_BOC Sciences - 코아사이언스 receptor (GLP-1R) agonist. Tirzepatide is being studied for its potential use in the treatment of .......
- Salcaprozate sodium [463293][CAS no. 203787-91-1 (sodium)]_MedKoo Biosciences - 코아사이언스 .# 463293 / Size: inquiry Description: Salcaprozate sodium (SNAC) is a clinically utilized oral drug increases the oral bioavailability of peptides and proteins such as insulin and glucagon-like peptide-1 (GLP
- Tirzepatide Acetate [TP1111L][Cas No. 2023788-19-2 (free base)]_TargetMol - 코아사이언스 LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.
- Tirzepatide acetate [B1370-447164][CAS no. 2931515-08-9]_BOC Sciences - 코아사이언스 .# B1370-447164 / Size: 100mg Tirzepatide acetate is a dual GIP and GLP-1 receptor agonist used as a CAS NO.: 2931515-08-9 Category: Inhibitor Tag/Targets: GIP Receptor Glucagon-Like Peptide 1 (GLP-1) Molecular
- 저탄고지 케톤 식단이 알츠하이머, 파킨슨 병 치료에 도움이 될까? (KD provides ketone bodies as an alternative brain fuel when glucose use is impaired, potentially rescuing 하지만 최근에는 위고비 같은 GLP-1 약물과 함께 유행이 사그라진 느낌입니다. 하지만 의학적인 연구는 여전히 활발히 진행 중입니다.
